Skip to main content
2025 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Manufacturing & Analytical Characterization
Chalk Talk

Softgel and Fast-Dissolving ODT Platforms: Driving Lifecycle Management Through Patient-Centric Design

Monday, November 10, 2025
9:30 AM - 10:15 AM CT
Location:Spotlight Stage B, Aisle 2500, Exhibit Hall

Sponsored By 
Manufacturing and Analytical Characterization Partner Presentation-Manufacturing & Bioprocessing

Description: Lifecycle Management (LCM) has become a strategic necessity in a competitive pharmaceutical environment where innovation, speed, and patient relevance drive success. This session explores how softgel and fast-dissolving orally disintegrating tablet (ODT) platforms enable effective LCM strategies that revitalize assets, enhance therapeutic performance, and improve patient experiences. Participants will learn how to integrate development, manufacturing, and supply considerations to accelerate reformulation and streamline scale-up. Real-world case studies will showcase applications that expand patient access, oncology formulations that overcome solubility and tolerability barriers, and lifecycle strategies that maintain market competitiveness. The session highlights how integrating formulation science with scalable technologies and patient-centered approaches supports a proactive model of LCM, ensuring long-term product value and market differentiation.

Learning Objectives:

  • Recognize how Softgel and Fast-Dissolving ODT Platforms platform support proactive lifecycle management and patient-centered product design.
  • Learn how reformulation and scalable manufacturing enable market competitiveness and expanded patient access.
  • Evaluate case studies on oncology and chronic disease applications enhancing therapeutic performance and patient outcomes.